Lipopolysaccharide Inhibits Alpha Epithelial Sodium Channel Expression via MiR-124-5p in Alveolar Type 2 Epithelial
Yan Ding1, Yong Cui2, Zhiyu Zhou1
1Department of Stem Cells and Regenerative Medicine, College of Basic Medical Science, China Medical University, Shenyang 110122, China.
Abstract:
Mesenchymal stem cells (MSCs) have been a potential strategy in the pretreatment of pulmonary diseases, while the mechanisms of MSCs-conditioned medium (MSCs-CM) involved with microRNAs on the regulation of lung ion transport are seldom reported. We investigated the role of miR-124-5p in lipopolysaccharide-involved epithelial sodium channel (ENaC) dysfunction and explored the potential target of miR-124-5p. We observed the lower expression of miR-124-5p after the administration of MSCs-CM, and the overexpression or inhibition of miR-124-5p regulated epithelial sodium channel α-subunit (α-ENaC) expression at protein levels in mouse alveolar type 2 epithelial (AT2) cells. We confirmed that α-ENaC is one of the target genes of miR-124-5p through dual luciferase assay and Ussing chamber assay revealed that miR-124-5p inhibited amiloride-sensitive currents associated with ENaC activity in intact H441 monolayers. Our results demonstrate that miR-124-5p can decrease the expression and function of α-ENaC in alveolar epithelial cells by targeting the 3'-UTR. The involvement of MSCs-CM in lipopolysaccharide-induced acute lung injury cell model could be related to the downregulation of miR-124-5p on α-ENaC, which may provide a new target for the treatment of acute lung injury.
Insights
Mesenchymal stem cells-conditioned medium (MSCs-CM) may treat lung injury by reducing miR-124-5p, which lowers epithelial sodium channel (ENaC) expression and function. This study reveals miR-124-5p as a potential therapeutic target for acute lung injury.
Area of Science:
- Biomedical research
- Molecular biology
- Pulmonary medicine
Background:
- Mesenchymal stem cells-conditioned medium (MSCs-CM) shows promise for pulmonary diseases.
- Mechanisms of MSCs-CM involving microRNAs in lung ion transport are not well understood.
- Acute lung injury involves epithelial sodium channel (ENaC) dysfunction.
Purpose of the Study:
- Investigate the role of miR-124-5p in lipopolysaccharide-induced ENaC dysfunction.
- Identify the molecular targets of miR-124-5p in alveolar epithelial cells.
- Explore the therapeutic potential of targeting miR-124-5p in acute lung injury.
Main Methods:
- Quantitative analysis of miR-124-5p expression after MSCs-CM administration.
- Manipulation of miR-124-5p levels in mouse alveolar type 2 epithelial (AT2) cells.
- Dual luciferase and Ussing chamber assays to confirm target interaction and functional impact.
Main Results:
- MSCs-CM administration led to decreased miR-124-5p expression.
- miR-124-5p directly targets the 3'-untranslated region of α-ENaC.
- miR-124-5p inhibition of α-ENaC expression and amiloride-sensitive currents was confirmed.
Conclusions:
- miR-124-5p regulates α-ENaC expression and function in alveolar epithelial cells.
- Downregulation of miR-124-5p by MSCs-CM may contribute to its protective effects in acute lung injury.
- Targeting miR-124-5p offers a potential therapeutic strategy for acute lung injury.
Related Concept Videos
MicroRNAs
MicroRNAs


